Executive Intelligence

John Farquhar

Founder

John Farquhar is listed as a founder of HeartFlow based in United States on Brel Digital’s verified company intelligence record.

Company Intelligence Official Website
In this profile

Quick Facts

  • Role Founder
  • Company HeartFlow
  • Country United States
  • Industry AI in Healthcare
  • Founded 2010
  • Known For HeartFlow is one of the few publicly traded pure-play cardiovascular AI diagnostics companies, and its FISH&CHIPS…
  • Status Public
  • Last Reviewed Jul 2026

Executive Summary

John Farquhar appears in Brel Digital’s verified company_founders attribution for HeartFlow based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted. Company context (from the verified HeartFlow profile): Public cardiology AI company (Nasdaq: HTFL) analyzing coronary blood flow from CT imaging Why the company matters (verified company field): HeartFlow is one of the few publicly traded pure-play cardiovascular AI diagnostics companies, and its FISH&CHIPS analysis of 90,000 patients gives outside observers a rare disclosed evidence base for AI-guided coronary decision-making. Official company website on file: https://www.heartflow.com. Readers should consult that site and the Sources section for primary evidence. Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2010 Company founded

    HeartFlow was founded in 2010 per the company profile source on file.

    Source
  2. 2010 Development

    2010: HeartFlow founded in Mountain View; John Farquhar among founders.

    Source
  3. 2025 Product

    December 2025: HeartFlow announced FISH&CHIPS analysis covering 90,000 patients, per investor relations release.

    Source
  4. Development

    Public listing: HeartFlow trades on Nasdaq under ticker HTFL.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

AI in Healthcare Open industry

John Farquhar appears in Brel Digital’s verified company_founders attribution for HeartFlow based in United States in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.

Company context (from the verified HeartFlow profile): Public cardiology AI company (Nasdaq: HTFL) analyzing coronary blood flow from CT imaging

Why the company matters (verified company field): HeartFlow is one of the few publicly traded pure-play cardiovascular AI diagnostics companies, and its FISH&CHIPS analysis of 90,000 patients gives outside observers a rare disclosed evidence base for AI-guided coronary decision-making.

Official company website on file: https://www.heartflow.com. Readers should consult that site and the Sources section for primary evidence.

Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Request a correction if you represent this company or believe information is inaccurate.

The AI Brief

Founder and company intelligence, weekly.

Subscribe